Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-25

Clinical Trial Update: Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and tolerability of an oral polyethylene glycol 3350 solution (MK-8114-003) in adults with constipation; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene Glycol 3350 solution (polyethylene glycol 3350)

Snippet

Sponsor: Bayer | Conditions: Constipation | Phase 2 | Status: COMPLETED | Results posted: 2014-09-25